American Association for Cancer Research

Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances

Image: Lymphoid aggregates organized into germinal center like structures are found infiltrating pancreatic cancers following immunotherapy. Credit: Lei Zheng and Elizabeth Jaffee, Johns Hopkins University, Baltimore, Maryland Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances
December 2-5, 2012
InterContinental Miami Hotel
Miami, Florida

Presented in conjunction with the Cancer Immunology Working Group

CONFERENCE CO-CHAIRPERSONS:
Elizabeth M. Jaffee, Sidney Kimmel Cancer Center at Johns Hopkins, Baltimore, MD
Stanley Riddell, Fred Hutchinson Cancer Research Center, Seattle, WA
Glenn Dranoff, Dana-Farber Cancer Institute, Boston, MA

* Adobe Acrobat Reader required

Please visit the AACR Meetings & Workshops Calendar for a complete list of upcoming programs.

The central theme of this conference was to present and discuss the rapidly developing advances in basic and translational tumor immunology. Central to this theme were updates on the immunology field’s adoption of new technologies in molecular biology, proteomics, engineering, and imaging that are providing novel insights into the cytokine/chemokine, receptor:ligand checkpoint, genetic, and epigenetic regulatory pathways that influence the inflammatory changes that are critical to cancer development and progression. In addition, the conference highlighted new advances in targeting these pathways for cancer prevention and treatment. Building on AACR's previously successful Cancer Immunology Special Conferences, the conference provided for highly stimulating discussions that will further the scientific and translational goals of the field and allow for more effective exchange between cancer immunologists and scientists in other fields with expertise that can be applied to cancer immunology.

 

LEAD SUPPORTER


Novartis Oncology

 

MAJOR SUPPORTERS


Amgen 




Bristol-Myers Squibb Oncology Division


Celgene


 

SUPPORTERS


Gilead         Immudex